Endocrinology Test
|
|
| 1. The GH systemic effect is mediated by: |
|
|
| 2. Aldosterone release is responsible for: |
|
|
| 3. The following is false regarding nonfunctional pituitary adenoma: |
|
|
| 4. In Graves disease the 1st line treatment is: |
|
|
| 5. First line therapy in prolactinomas is represented by: |
|
|
| 6. The following are true regarding fine needle aspiration for thyroid nodules: |
|
|
| 7. The corticotroph line insufficiency: |
|
|
| 8. The following are true about thyroid supplemental therapy: |
|
|
| 9. FSH has the following effects in ovaries: |
|
|
| 10. Sporadic hyperparathyroidism : |
|
|
| 11. Bone formation agents used as osteoporosis treatment are represented by: |
|
|
| 12. Which statements are true: |
|
|
| 13. Which statements regarding differentiated thyroid cancer are true: |
|
|
| 14. The mechanisms of hypertension in hypothyroidism are the following : |
|
|
| 15. Patients with Cushing syndrome can present: |
|
|
| 16. Under the possible effects of growth hormone we can observe: |
|
|
| 17. In case of gonadotroph insufficiency in females the supplemental therapy has the following contraindications: |
|
|
| 18. The following situations can induce hypertension: |
|
|
| 19. The lab diagnostic of pheocromocytoma is made by: |
|
|
| 20. Characteristics of asymptomatic hyperparathyroidism are: |
|
|
| 21. Which statements regarding pheocromocytoma are true: |
|
|
| 22. The following are true regarding nodular thyroid disease: |
|
|
| 23. In Graves disease the indications for radioactive iodine treatment are: |
|
|
| 24. Absolute contraindication for combine oral contraceptive use are: |
|
|
| 25. In primary hyperaldosteronism: |
|